Harborside Inc (CSE: HBOR) is set to begin trading on Monday, June 10. The firm filed it’s filing statement with regulators yesterday, and is now available via Sedar.
“The start of trading represents a significant milestone for Harborside, and we’re grateful for the support that we’ve received from the CSE throughout the process. We’re excited to move forward as a public company, with a vehicle that attracts growth capital from new investors, and continue maintaining Harborside’s status as California’s premier cannabis operator.”
Andrew Berman, CEO of Harborside
In the release issued this morning, Harborside, formerly Lineage Grow, addressed that 9,668,162 subordinate voting shares were issued and outstanding as of the date of the filing statement. However, due to further issuance of subordinate shares as of today’s date 12,848,203 are issued and outstanding, with a further 44,353,718 reserved for issuance. Numerous however are subject to current lockup agreements and as such are not free trading.
Harborside is a multi state operator with cannabis operations in both the states of California as well as that of Oregon. The firm currently holds a significant market share within California, wherein it either owns or controls multiple dispensaries. The firm was one of the first to begin legally operating in the Golden State, with its first medical dispensary opening up in 2006.
Sponsored · Antimony Resources
Information for this briefing was found via Sedar and Harborside Inc. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.
